Javier Cerra-Franco, MD
Gastroenterology · Cayey, PRNPI 1134487945
Payments from drug & device makers
What this record shows
9 manufacturers reported payments, led by Medtronic at 35.3% of the total. Reporting peaked in 2022 at $2,173 and has fallen 66.8% since, to $722 in 2025.
Across 63 payments — averaging $90.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Boston Scientific$2K
- AbbVie$884
- Olympus Latin America, Inc.$537
- Olympus America Inc.$486
- Sanofi$140
- plus $116 from 3 others
What the payments were for
- Travel & lodging$2,69947%
- Food & beverage$3,00053%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 14 | $2,011 |
| Boston Scientific | 14 | $1,524 |
| AbbVie | 19 | $884 |
| Olympus Latin America, Inc. | 5 | $537 |
| Olympus America Inc. | 4 | $486 |
| Sanofi | 1 | $140 |
| E.r. Squibb & Sons, L.L.C. | 3 | $56 |
| Inari Medical, Inc. | 2 | $38 |
| Johnson & Johnson | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DFS$1,318
- SPYGLASS$490
- GENERAL - THERAPIES$367
- Barrx$356
- EVIS EXERA II ULTRASOUND GASTROVIDEOSCOPE$264
- Mavyret$200
- EUS Devices$148
- HANAROSTENT LowAxTM Colon/Rectum(NNN)$127
- Skyrizi$125
- EVIS EXERA III COLONOVIDEOSCOPE$125
- Rinvoq$125
- EVIS EXERA lll COLONOVIDEOSCOPE$115
- EVIS EXERA III DUODENOVIDEOSCOPE$115
- Endocuff Vision$115
- AGILE$106
How this compares
$5,699 in reported general payments places this provider in the 75th percentile of 198 gastroenterology providers in Puerto Rico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SuprepSodium, Potassium,mag Sulfates | 133 | $15,738 |
| SutabSod Sulf/Pot Chloride/Mag Sulf | 36 | $5,925 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 69 | $5,627 |
| Ursodiol | 27 | $2,129 |
| Colestipol Hcl | 23 | $1,341 |
| Omeprazole | 170 | $1,082 |
| Buspirone Hcl | 25 | $175 |
| Carvedilol | 14 | $61 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Cayey
- Ahmed Morales JorgeCoto Laurel$214K
- Barbara Rosado CarrionPonce$176K
- Rafael Pastrana LabordeHato Rey$76K
- Miguel de Varona-NegronCaguas$68K
- Marcia Cruz CorreaSan Juan$62K
- Francisco CebolleroMayaguez$52K
- Loscar SantiagoSan Juan$39K
- Henry Gonzalez RiveraSan Juan$34K
- Hector LozanoSan Juan$28K
- Carlos MicamesMayaguez$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.